ES2133740T3 - Espiro-compuestos sustituidos para el tratamiento de la inflamacion. - Google Patents
Espiro-compuestos sustituidos para el tratamiento de la inflamacion.Info
- Publication number
- ES2133740T3 ES2133740T3 ES95909447T ES95909447T ES2133740T3 ES 2133740 T3 ES2133740 T3 ES 2133740T3 ES 95909447 T ES95909447 T ES 95909447T ES 95909447 T ES95909447 T ES 95909447T ES 2133740 T3 ES2133740 T3 ES 2133740T3
- Authority
- ES
- Spain
- Prior art keywords
- compounds
- inflammation
- hydrido
- halo
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/70—Sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/22—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
- C07C311/29—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/14—Sulfones; Sulfoxides having sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/16—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C317/22—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/64—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and sulfur atoms, not being part of thio groups, bound to the same carbon skeleton
- C07C323/65—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and sulfur atoms, not being part of thio groups, bound to the same carbon skeleton containing sulfur atoms of sulfone or sulfoxide groups bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/32—Sulfur atoms
- C07D213/34—Sulfur atoms to which a second hetero atom is attached
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/61—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
- C07D317/56—Radicals substituted by sulfur atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Hydrogenated Pyridines (AREA)
Abstract
SE DESCRIBE UNA CLASE DE COMPUESTOS DE ESPIRO SUSTITUIDO PARA SU USO EN EL TRATAMIENTO DE LA INFLAMACION Y LOS TRASTORNOS ASOCIADOS CON LA INFLAMACION. LOS COMPUESTOS DE INTERES PARTICULAR SE DEFINEN POR LA FORMULA (III), EN DONDE N ES UN NUMERO SELECCIONADO A PARTIR DE 0, 1 Y 2; EN DONDE R{SUP,6} ES SELECCIONADO A PARTIR DE HIDRIDO Y HALO; EN DONDE R{SUP,7} ES SELECCIONADO A PARTIR DE HIDRIDO Y HALO; EN DONDE R{SUP,8} ES SELECCIONADO A PARTIR DE HIDRIDO, HALO, ALQUILO DE CADENA CORTA, ALCOXI DE CADENA CORTA, HALOALQUILO DE CADENA CORTA, HALOALCOXI DE CADENA CORTA, E HIDROXILO; EN DONDE R{SUP,9} ES SELECCIONADO A PARTIR DE HIDRIDO, HALO Y ALQUILO DE CADENA CORTA; O EN DONDE R{SUP,8} Y R{SUP,9} FORMAN JUNTOS METILENDIOXI; Y EN DONDE R{SUP,11} ES SELECCIONADO A PARTIR DE ALQUILO DE CADENA CORTA Y AMINO; O UNA SAL FARMACEUTICAMENTE ACEPTABLE DE LOS MISMOS.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/194,762 US5393790A (en) | 1994-02-10 | 1994-02-10 | Substituted spiro compounds for the treatment of inflammation |
US08/341,734 US5736579A (en) | 1994-02-10 | 1994-11-18 | Substituted spiro compounds for the treatment of inflammation |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2133740T3 true ES2133740T3 (es) | 1999-09-16 |
Family
ID=26890383
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES95909447T Expired - Lifetime ES2133740T3 (es) | 1994-02-10 | 1995-02-07 | Espiro-compuestos sustituidos para el tratamiento de la inflamacion. |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP0743938B1 (es) |
JP (1) | JPH09509159A (es) |
AT (1) | ATE179168T1 (es) |
AU (1) | AU692231B2 (es) |
CA (1) | CA2182950A1 (es) |
DE (1) | DE69509223T2 (es) |
DK (1) | DK0743938T3 (es) |
ES (1) | ES2133740T3 (es) |
GR (1) | GR3030810T3 (es) |
WO (1) | WO1995021817A1 (es) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2294879A (en) * | 1994-10-19 | 1996-05-15 | Merck & Co Inc | Cylcooxygenase-2 Inhibitors |
ES2191069T3 (es) * | 1994-12-21 | 2003-09-01 | Merck Frosst Canada Inc | Diaril-2-(5h)-furanonas como inhibidores de cox-2. |
EP0892791B1 (en) | 1996-04-12 | 2003-03-05 | G.D. Searle & Co. | N-[[4-(5-METHYL-3-PHENYLISOXAZOL-4-YL]PHENYL]SULFONYLPROPYLAMIDE and its SODIUMSALT AS PRODRUGS OF COX-2 INHIBITORS |
FR2751964B1 (fr) * | 1996-08-01 | 1998-10-30 | Union Pharma Scient Appl | Nouveaux derives diarylmethylene carbocycliques, leurs procedes de preparation, et leurs utilisations en therapeutique |
US6025353A (en) * | 1997-11-19 | 2000-02-15 | G.D. Searle & Co. | Method of using cyclooxygenase-2 inhibitors as anti-angiogenic agents |
CO5190664A1 (es) | 1999-06-30 | 2002-08-29 | Pfizer Prod Inc | Terapia de combinacion para el tratamiento de migrana administracion de un receptor 5ht, cafeina y un inhibidor de ciclooxigenasa-2 |
DE10001166A1 (de) | 2000-01-13 | 2001-07-19 | Merckle Gmbh | Anellierte Pyrrolverbindungen, diese enthaltende pharmazeutische Mittel und deren Verwendung |
PT1303265E (pt) | 2000-07-20 | 2007-10-09 | Lauras As | ''utilização de inibidores da cox-2 como imuno-estimulantes, no tratamento do vih ou da sida'' |
AR038957A1 (es) | 2001-08-15 | 2005-02-02 | Pharmacia Corp | Terapia de combinacion para el tratamiento del cancer |
EP1416028A1 (en) * | 2002-10-30 | 2004-05-06 | Covion Organic Semiconductors GmbH | New method for the production of monomers useful in the manufacture of semiconductive polymers |
EP1534305B9 (en) | 2003-05-07 | 2007-03-07 | Osteologix A/S | Treating cartilage / bone conditions with water-soluble strontium salts |
CA3209491A1 (en) | 2021-03-15 | 2022-09-22 | Saul Yedgar | Hyaluronic acid-conjugated dipalmitoyl phosphatidyl ethanolamine in combination with non-steroidal anti-inflammatory drugs (nsaids) for treating or alleviating inflammatory disease |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5344991A (en) * | 1993-10-29 | 1994-09-06 | G.D. Searle & Co. | 1,2 diarylcyclopentenyl compounds for the treatment of inflammation |
-
1995
- 1995-02-07 AT AT95909447T patent/ATE179168T1/de not_active IP Right Cessation
- 1995-02-07 CA CA002182950A patent/CA2182950A1/en not_active Abandoned
- 1995-02-07 EP EP95909447A patent/EP0743938B1/en not_active Expired - Lifetime
- 1995-02-07 AU AU17408/95A patent/AU692231B2/en not_active Ceased
- 1995-02-07 DE DE69509223T patent/DE69509223T2/de not_active Expired - Fee Related
- 1995-02-07 WO PCT/US1995/001385 patent/WO1995021817A1/en active IP Right Grant
- 1995-02-07 ES ES95909447T patent/ES2133740T3/es not_active Expired - Lifetime
- 1995-02-07 DK DK95909447T patent/DK0743938T3/da active
- 1995-02-07 JP JP7521256A patent/JPH09509159A/ja not_active Ceased
-
1999
- 1999-07-20 GR GR990401898T patent/GR3030810T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
GR3030810T3 (en) | 1999-11-30 |
DE69509223T2 (de) | 1999-09-16 |
WO1995021817A1 (en) | 1995-08-17 |
DK0743938T3 (da) | 1999-10-25 |
DE69509223D1 (de) | 1999-05-27 |
AU1740895A (en) | 1995-08-29 |
EP0743938B1 (en) | 1999-04-21 |
AU692231B2 (en) | 1998-06-04 |
ATE179168T1 (de) | 1999-05-15 |
JPH09509159A (ja) | 1997-09-16 |
CA2182950A1 (en) | 1995-08-17 |
EP0743938A1 (en) | 1996-11-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0794942T3 (da) | Substituerede biphenylforbindelser til behandling af inflammation | |
EA200100451A1 (ru) | Замещенные аналоги бензопирана для лечения воспаления | |
DE60220422D1 (de) | Substituierte pyrazoloverbindungen zur behandlung von entzündungen | |
EA199900853A1 (ru) | Замещенные производные бензопирана для лечения воспалительных процессов | |
BR0212733A (pt) | Composto, composição farmacêutica, uso de um composto, e, método para o tratamento de um distúrbio afetivo | |
ES2181812T3 (es) | Formulaciones y procedimientos para reducir la irritacion de la piel. | |
BR9909844A (pt) | Processo para sintetizar um composto, e, composto. | |
EA200100412A1 (ru) | Замещенные 3-цианохинолины в качестве ингибиторов протеинтирозинкиназ | |
ES2133740T3 (es) | Espiro-compuestos sustituidos para el tratamiento de la inflamacion. | |
BR9812837A (pt) | Processo para fazer um composto, e, composto | |
ES2163723T3 (es) | Nuevos compuestos moduladores de los receptores hormonales, las composiciones que los incluyen y su utilizacion en terapia. | |
ATE297903T1 (de) | Substituierte phenyluracile | |
BR8900834A (pt) | 1,2,4-triazinodionas substituidas e processo para sua preparacao;compostos intermediarios para as mesmas e processos para sua preparacao;composicoes contra protozoarios parasitarios;processo para o combate dos mesmos;e processo para preparacao de composicoes contra protozoarios parasitarios | |
BR9608506A (pt) | "2-Amino-benzoxazinonas para o tratamento de infeccões viróticas | |
AR000813A1 (es) | Procedimiento para la obtencion de n-aril y n-heteroarilhidroxilaminas | |
BR9612074A (pt) | Novos 4-(1h-benzimidazol-2-il)(1,4) diazepanos substituidos úteis para o tratamento de doenças alérgicas | |
PT99468A (pt) | Processo para a preparacao de compostos cefem 7-actil-3-(carbamoiloxi substituido) com propriedades antibacterianas | |
EA200100141A1 (ru) | Терапевтическая композиция на основе изофлавоноидов для применения в лечении опухолей цитотоксическими агентами | |
DE69118204D1 (de) | Bekämpfung von parasitischen nematoden | |
ES2120211T3 (es) | Mezclas fungicidas. | |
ES2140683T3 (es) | Procedimiento para preparar compuestos de benzopirano. | |
DK0713485T3 (da) | Thiocarbamoylforbindelser som mikrobicider | |
DK1140932T3 (da) | Derivater af benzo-1,8-naphtyridin | |
DE69428127D1 (de) | Schädlingsbekämpfungsmittel |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 743938 Country of ref document: ES |